FDA Approves Sunharbo, First Factor XIa Drug, to Cut Repeat Strokes by a Quarter
The US Food and Drug Administration has approved Sunharbo, the first drug of its kind to block the clotting protein Factor XIa, offering new protection against a second stroke...